NO166126C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.

Info

Publication number
NO166126C
NO166126C NO862621A NO862621A NO166126C NO 166126 C NO166126 C NO 166126C NO 862621 A NO862621 A NO 862621A NO 862621 A NO862621 A NO 862621A NO 166126 C NO166126 C NO 166126C
Authority
NO
Norway
Prior art keywords
sup
acid derivatives
preparation
group
therapeutic active
Prior art date
Application number
NO862621A
Other languages
English (en)
Norwegian (no)
Other versions
NO862621L (no
NO166126B (no
NO862621D0 (no
Inventor
Kuniyoshi Masuzawa
Seigo Suzue
Keijo Hirai
Takayoshi Ishizaki
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of NO862621D0 publication Critical patent/NO862621D0/no
Publication of NO862621L publication Critical patent/NO862621L/no
Publication of NO166126B publication Critical patent/NO166126B/no
Publication of NO166126C publication Critical patent/NO166126C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO862621A 1985-06-28 1986-06-27 Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. NO166126C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60141813A JPH0635457B2 (ja) 1985-06-28 1985-06-28 ピリドンカルボン酸誘導体およびその製造方法

Publications (4)

Publication Number Publication Date
NO862621D0 NO862621D0 (no) 1986-06-27
NO862621L NO862621L (no) 1986-12-29
NO166126B NO166126B (no) 1991-02-25
NO166126C true NO166126C (no) 1991-06-05

Family

ID=15300723

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862621A NO166126C (no) 1985-06-28 1986-06-27 Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.

Country Status (16)

Country Link
US (1) US4753953A (de)
EP (1) EP0208210B1 (de)
JP (1) JPH0635457B2 (de)
KR (1) KR930005002B1 (de)
CN (1) CN1010312B (de)
AT (1) ATE57699T1 (de)
AU (1) AU589427B2 (de)
CA (1) CA1262349A (de)
DE (1) DE3675087D1 (de)
DK (1) DK171330B1 (de)
ES (1) ES2000185A6 (de)
FI (1) FI85697C (de)
HU (1) HU208128B (de)
MX (1) MX162950B (de)
NO (1) NO166126C (de)
PT (1) PT82854B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US5147871A (en) * 1986-07-03 1992-09-15 Hoffmann La-Roche, Inc. Anti-bacterial cephalosporin compounds
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
JP2603638B2 (ja) * 1987-07-08 1997-04-23 第一製薬株式会社 光学異性体の分析法及び分取法
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
US5159077A (en) * 1989-07-21 1992-10-27 Hoffmann-La Roche Inc. Penam antibacterial compounds
MY109714A (en) * 1990-10-18 1997-04-30 Daiichi Seiyaku Co Process for preparing 8-chloroquinolone derivatives
NO179912C (no) * 1990-11-28 1997-01-08 Daiichi Seiyaku Co Analogifremgangsmåte for fremstilling av et terapeutisk virksomt optisk aktivt pyridobenzoksazinderivat
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
AU697025B2 (en) * 1995-01-24 1998-09-24 Hokuriku Seiyaku Co. Ltd Quinoline carboxylic acid
US7514451B2 (en) 2003-09-10 2009-04-07 Kyorin Pharmaceutical Co., Ltd. 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative
US20070191356A1 (en) * 2004-02-02 2007-08-16 Makoto Takemura Pyridobenzoxazine derivative
EP1757598A4 (de) * 2004-05-13 2010-07-21 Daiichi Seiyaku Co Substituiertes pyrrolidinderivat
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
CA2688008A1 (en) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
FR2961207B1 (fr) * 2010-06-09 2013-01-18 Oreal Utilisation d'un derive de 4- carboxy 2-pyrrolidinone comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant ; nouveaux composes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
US4620007A (en) * 1980-09-03 1986-10-28 Bayer Aktiengesellschaft 6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
JPS5788183A (en) * 1980-11-21 1982-06-01 Dai Ichi Seiyaku Co Ltd Pyridobenzoxazine derivative
JPS5872589A (ja) * 1981-10-28 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕〔１，４〕ベンゾオキサジン誘導体
PH22140A (en) * 1982-06-29 1988-06-01 Daiichi Seiyaku Co Tricyclic compounds
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60260577A (ja) * 1984-06-06 1985-12-23 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3580183D1 (de) * 1984-04-26 1990-11-29 Abbott Lab Antibakterielle chinobenzoxazin-verbindungen.
US4542133A (en) * 1984-04-26 1985-09-17 Abbott Laboratories Methylenedioxy quino-benoxazine derivatives and antibacterial use
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4604401A (en) * 1984-07-20 1986-08-05 Warner-Lambert Company Antibacterial agents III
JPH0670032B2 (ja) * 1984-11-22 1994-09-07 大日本製薬株式会社 アミノピロリジン誘導体、そのエステルおよびその塩
JPS61137885A (ja) * 1984-12-08 1986-06-25 Dainippon Pharmaceut Co Ltd １，８−ナフチリジン誘導体、そのエステルおよびその塩
JPS61148179A (ja) * 1984-12-20 1986-07-05 Dainippon Pharmaceut Co Ltd 新規ナフチリジン誘導体、そのエステルおよびその塩
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
AU585995B2 (en) * 1985-06-20 1989-06-29 Daiichi Pharmaceutical Co., Ltd. Optically active pyridobenzoxazine derivatives and intermediates thereof
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体

Also Published As

Publication number Publication date
US4753953A (en) 1988-06-28
FI862757A (fi) 1986-12-29
PT82854B (pt) 1988-05-27
CA1262349A (en) 1989-10-17
KR930005002B1 (ko) 1993-06-11
PT82854A (en) 1986-07-01
MX162950B (es) 1991-07-22
ATE57699T1 (de) 1990-11-15
NO862621L (no) 1986-12-29
AU589427B2 (en) 1989-10-12
FI862757A0 (fi) 1986-06-27
NO166126B (no) 1991-02-25
CN86104479A (zh) 1987-02-04
FI85697C (fi) 1992-05-25
AU5919086A (en) 1987-01-08
FI85697B (fi) 1992-02-14
DK171330B1 (da) 1996-09-09
KR870000322A (ko) 1987-02-17
ES2000185A6 (es) 1988-01-01
HUT43051A (en) 1987-09-28
DE3675087D1 (de) 1990-11-29
DK306586A (da) 1986-12-29
EP0208210B1 (de) 1990-10-24
CN1010312B (zh) 1990-11-07
DK306586D0 (da) 1986-06-27
NO862621D0 (no) 1986-06-27
EP0208210A1 (de) 1987-01-14
HU208128B (en) 1993-08-30
JPH0635457B2 (ja) 1994-05-11
JPS624284A (ja) 1987-01-10

Similar Documents

Publication Publication Date Title
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO171785C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO934536D0 (no) Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
NO168418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
GR3006108T3 (de)
DE3782235D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees